The sensitive and specific detection of anti-AChR and anti-MuSK autoantibodies has become an essential laboratory investigation in evaluating patients with MG, because seropositivity has diagnostic, prognostic, and therapeutic implications [15,16,17,18,19]. This evidence concerns the gene MUSK and myasthenia gravis.